Papel da saliva do Lutzomyia intermedia na infecção por Leismania braziliensis: desenvolvimento de vacinas para Leishmaniose Tegumentar

Moura, Tatiana Rodrigues de.
Salvador; s.n; 2008. 109 p. ilus, graf.
Tese em Português | LILACS | ID: lil-540656

Documentos relacionados

  1. Cross-protective efficacy from a immunogen firstly identified in Leishmania infantum against tegumentary leishmaniasis.
  2. Canines vaccinated against visceral leishmaniasis develop a serological response to the Leishmania braziliensis antigen
  3. Canines vaccinated against visceral leishmaniasis develop a serological response to the Leishmania braziliensis antigen
  4. Cross-protective efficacy of Leishmania infantum LiHyD protein against tegumentary leishmaniasis caused by Leishmania major and Leishmania braziliensis species.
  5. Antigenic extracts of Leishmania braziliensis and Leishmania amazonensis associated with saponin partially protects BALB/c mice against Leishmania chagasi infection by suppressing IL-10 and IL-4 production.
  6. A vaccine combining two Leishmania braziliensis proteins offers heterologous protection against Leishmania infantum infection.
  7. In silico characterization of multiple genes encoding the GP63 virulence protein from Leishmania braziliensis: identification of sources of variation and putative roles in immune evasion.
  8. Intranasal vaccination with leishmanial antigens protects golden hamsters (Mesocricetus auratus) against Leishmania (Viannia) Braziliensis infection.
  9. Effect on cellular recruitment and the innate immune response by combining saponin, monophosphoryl lipid-A and Incomplete Freund's Adjuvant with Leishmania (Viannia) braziliensis antigens for a vaccine formulation.
  10. Probing the efficacy of a heterologous Leishmania/L. Viannia braziliensis recombinant enolase as a candidate vaccine to restrict the development of L. infantum in BALB/c mice.